Ad hoc Announcement according to Art. 17 Market Abuse Regulation
Stock splits can be undertaken for several reasons. They can bring a stock's price down to make it more affordable for a wider range of investors. They can increase a stock price if it's too low, which...
Shares of Hologic HOLX recorded a new 52-week low of $69.46 during Monday’s trading before finishing slightly higher at $70.29. Yesterday, the stock ended at $70.20, marking the lowest close in recent...
QIAGEN launched custom tools for designing microbial assays, enhancing digital PCR and NGS capabilities for researchers.Quiver AI SummaryQIAGEN has launched two innovative tools designed to enhance microbial...
On Monday, Hologic HOLX released its fiscal 2024 fourth-quarter financial report after the closing bell, with revenues slightly surpassing the consensus mark. The bottom line fell short of estimates...
QIAGEN N.V.’s QGEN third-quarter 2024 adjusted earnings per share (EPS) were 57 cents, 58 cents at the constant exchange rate (CER). The reported figure increased 14% from the 2023 comparable figure...
QIAGEN N.V. QGEN is well-poised to grow in the coming quarter, driven by its strategic alliances with researchers and pharma companies. The company’s expansive next-generation sequencing (NSG) portfolio...
/Bio-Rad%20Laboratories%20Inc_%20magnified-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
Despite Bio-Rad Laboratories’ underperformance relative to the healthcare sector over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.
Shares of Hologic HOLX are showing impressive gains of late, trading quite near its 52-week high of $84.67. The stock closed Thursday at $80.99, just 4.3% below the highest point. In the past three months,...